TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HROW

Harrow Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

30.50$ -0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Harrow Health Inc (HROW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 417 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HROW
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
22 27 26 28 26 24 21 26 28 49 67 65 55 59 47 49 59 57 56 107 103 98 98 98 99 157 217 224 286 312 296 307 352 389 364 345 363 399 420 417
9.0 15 14 10 10 8.8 7.4 8.7 12 33 39 38 32 36 26 30 41 41 41 93 91 61 62 65 64 118 52 60 110 139 125 139 147 190 170 155 178 212 226 229
2.4 8.9 7.4 4.2 3.9 4.0 2.7 4.2 6.3 6.6 4.3 4.0 3.4 4.7 3.9 3.9 5.5 4.1 6.3 73 58 42 42 46 45 96 19 23 66 74 69 71 73 47 67 53 74 73 95 84
2.4 8.9 7.4 4.2 3.9 4.0 2.7 4.2 6.3 28 32 32 26 30 18 23 33 33 32 85 68 51 51 52 49 96 19 23 74 83 76 71 73 47 67 56 74 73 95 84
3.1 2.9 3.0 2.9 2.7 1.6 1.6 1.6 1.8 2.0 2.9 3.0 3.5 2.0 2.0 2.0 2.2 2.7 3.3 3.7 4.2 4.5 6.0 6.8 6.9 6.4 12 18 19 36 29 52 54 117 77 79 78 111 101 119
1.9 1.8 2.0 1.8 2.4 2.2 2.0 2.2 2.5 1.8 2.4 2.7 2.4 3.3 4.0 3.8 4.0 4.0 4.5 3.9 3.9 4.2 4.4 5.1 5.3 6.5 9.1 8.6 8.9 11 11 9.4 10 11 11 12 13 14 16 17
7.3 7.3 7.1 6.6 6.4 6.2 6.0 6.0 6.1 6.4 12 5.9 5.2 5.4 5.1 5.0 4.8 4.5 4.2 9.7 4.8 3.1 3.0 2.8 11 3.5 3.6 3.6 – – – – – – – – – – – –
2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
3.0 3.0 2.9 2.9 2.9 2.9 2.9 2.9 3.0 3.1 3.1 3.2 2.3 2.3 2.3 2.0 2.0 2.5 1.9 1.9 1.9 17 17 17 20 26 154 150 163 160 159 157 191 187 182 178 174 175 182 177
19 21 21 20 22 21 21 23 24 25 29 30 31 32 32 34 35 31 28 84 87 87 88 93 98 130 196 202 211 242 235 248 294 320 308 296 316 347 391 402
5.8 9.9 12 5.5 6.1 5.8 5.9 8.2 10 12 11 9.9 11 12 13 13 14 11 10 8.1 10 9.7 9.2 13 18 19 18 23 19 49 42 54 95 91 187 249 65 96 91 102
0.4 4.9 7.2 0.5 0.6 0.7 1.5 2.3 3.5 4.0 4.7 2.0 2.0 2.4 3.2 4.1 4.3 4.5 3.3 0.5 0.4 0.3 0.5 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.5 0.5 109 184 0.9 0.9 0.9 0.9
3.8 3.5 3.9 3.3 4.0 3.9 3.9 4.7 5.9 5.0 6.1 6.9 8.1 7.4 7.3 5.5 5.5 3.6 5.2 3.9 4.7 5.2 5.6 8.0 7.0 19 14 11 6.0 21 13 20 25 39 37 23 19 35 26 34
9.7 7.9 6.0 12 14 14 14 13 13 12 11 13 13 12 12 14 13 12 11 71 71 72 72 72 72 104 169 170 182 183 184 185 186 220 113 38 243 243 292 292
2.8 6.4 5.3 7.6 3.7 2.6 0.1 3.7 4.5 25 37 35 24 28 15 16 25 27 28 23 17 11 10 5.7 1.2 27 22 22 76 70 61 59 58 70 56 50 47 52 29 15
-71 -77 -82 -80 -86 -89 -92 -90 -92 -74 -63 -65 -77 -74 -87 -87 -79 -77 -77 -80 -88 -95 -98 -104 -111 -109 -116 -120 -125 -134 -147 -154 -158 -151 -169 -164 -163 -157 -184 -201
13 19 19 23 20 21 21 23 22 24 27 25 26 26 26 26 27 26 27 27 27 27 27 27 27 29 30 30 34 35 35 36 36 36 36 39 39 37 37 37

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?